Klein Law Firm Reminds Investors of Class Action Lawsuits on Behalf of AUPH, BKKT and ARQQ Shareholders

NEW YORK, NY/ACCESSWIRE/May 18, 2022/ Klein Law Firm announces that class action lawsuits have been filed on behalf of shareholders of the following companies. There is no cost to participate in the trial. If you have suffered a claim, you have until the principal plaintiff’s deadline to ask the court to name you as the principal plaintiff.

Aurinia Pharmaceuticals Inc. AUPH
Class period: May 7, 2021 – February 25, 2022
Lead Applicant Deadline: June 14, 2022

During the Class Period, Aurinia Pharmaceuticals Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: (i) Aurinia was experiencing a decline in revenue; (ii) Aurinia’s 2022 sales outlook for the Company’s only product it offers for the treatment of adult patients with active lupus nephritis, LUPKYNIS, would be well below expectations; (iii) as a result, the Company had grossly overestimated LUPKYNIS’ business prospects; (iv) as a result, the Company had exaggerated its financial situation and/or its outlook for 2022; and (v) as a result, the Company’s public statements were materially false and misleading at all material times.

Learn more about your recoverable losses in AUPH: https://www.kleinstocklaw.com/pslra-1/aurinia-pharmaceuticals-inc-loss-submission-form?id=27424&from=1

Bakkt Holdings, Inc. f/k/a VPC Impact Acquisition Holdings BKKT
This lawsuit is on behalf of persons and entities that purchased or otherwise acquired: (a) Bakkt securities between March 31, 2021 and November 19, 2021, both dates inclusive; and/or (b) common shares of Bakkt Class A pursuant to and/or traceable to documents issued in connection with the business combination between the Company and Bakkt Holdings, LLC effected on or about October 15, 2021.
Lead Applicant Deadline: June 20, 2022

The BKKT lawsuit alleges that Bakkt Holdings, Inc. f/k/a VPC Impact Acquisition Holdings made materially false and/or misleading statements and/or failed to disclose during the Class Period that: (i) the Company had flawed financial controls; (ii) as a result, there were errors in the Company’s financial statements related to the misclassification of certain shares issued prior to the business combination between the Company and Bakkt Holdings, LLC; (iii) as a result, the Company should restate some of its financial statements; (iv) the Company has minimized the true extent and severity of such issues; (v) the Company has overstated its correction of its faulty financial controls; and (vi) as a result, the documents issued in connection with the business combination and the public statements of the defendants throughout the class period were materially false and/or misleading and did not contain the information that should have been included therein.

Learn more about your recoverable losses in BKKT: https://www.kleinstocklaw.com/pslra-1/bakkt-holdings-inc-fka-vpc-impact-acquisition-holdings-loss-submission-form?id=27424&from=1

Arqit Quantum Inc. f/k/a Centricus Acquisition Corp. ARQQ
This lawsuit is on behalf of: (i) all persons or entities who purchased or otherwise acquired Arqit securities between September 7, 2021 and April 18, 2022, inclusive; and/or (ii) all holders of Centricus securities on the record date of the extraordinary meeting of shareholders held on August 31, 2021 to consider the approval of the merger between Arqit and Centricus (the “Merger”) and entitled to vote on the Merger.
Lead Applicant Deadline: July 5, 2022

The ARQQ lawsuit alleges that throughout the Class Period, Arqit Quantum Inc. f/k/a Centricus Acquisition Corp. made materially false and/or misleading statements and/or failed to disclose that: (1) the encryption technology offered by Arqit would require widespread adoption of new telecommunications protocols and standards; (2) UK cybersecurity officials questioned the viability of Arqit’s proposed encryption technology at a meeting in 2020; (3) the UK government was not a client of Arqit but rather provided subsidies to Arqit; (4) Arqit had little more than a preliminary prototype of its encryption system at the time of the Merger; and (5) therefore, defendants’ statements about its business, operations and prospects were materially false and misleading and/or lacked reasonable basis at all relevant times.

Find out about your recoverable losses in the ARQQ: https://www.kleinstocklaw.com/pslra-1/arqit-quantum-inc-fka-centricus-acquisition-corp-loss-submission-form?id=27424&from=1

Your ability to participate in any collection does not require you to serve as the lead plaintiff. If you have suffered a loss during the course period and would like additional information, please contact J. Klein, Esq. by phone at 212-616-4899 or visit the web pages provided.

J. Klein, Esq. represents investors and participates in securities litigation involving financial fraud across the country. Lawyer advertisement. Prior results do not guarantee similar results.

CONTACT:
J. Klein, Esq.
Empire State Building
350 Fifth Avenue
59th floor
New York, NY 10118
jk@kleinstocklaw.com
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com

THE SOURCE: Klein law firm

See the source version on accesswire.com:


https://www.accesswire.com/701893/The-Klein-Law-Firm-Reminds-Investors-of-Class-Actions-on-Behalf-of-Shareholders-of-AUPH-BKKT-and-ARQQ